Inhibition of choroidal neovascularization by topical application of angiogenesis inhibitor vasostatin

PURPOSE: Choroidal neovascularization (CNV) is the leading cause of blindness in patients with age-related macular degeneration (AMD). This study evaluated the inhibitory effect of vasostatin (VS), an endogenous angiogenesis inhibitor, on CNV. METHODS: Anti-angiogenic activity of VS was evaluated in...

Descripción completa

Detalles Bibliográficos
Autores principales: Sheu, Shwu-Jiuan, Bee, Youn-Shen, Ma, Yi-Ling, Liu, Guei-Sheung, Lin, Hsiu-Chen, Yeh, Tse-Liang, Liou, Jau-Chen, Tai, Ming-Hong
Formato: Texto
Lenguaje:English
Publicado: Molecular Vision 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2746267/
https://www.ncbi.nlm.nih.gov/pubmed/19768130

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2746267/
https://www.ncbi.nlm.nih.gov/pubmed/19768130

Ejemplares similares